Joint Formulary & PAD

Esmolol hydrochloride - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
  • Intravenous infusion
Associated Icons :
SPC
Restrictions / Comments :
Important
Restricted to cardiology / Theatres / ITU / Resus

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Esmolol hydrochloride
Indication :
Arrhythmias
Group Name :
Keywords :
beta-blockers, supraventricular arrhythmias
Brand Names Include :
Brevibloc
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Esmolol hydrochloride is used to treat.

  • No records returned.